Product Overview
This product encapsulates 50µg/mL COVID-19 Spike Protein (Alpha Variant)-mRNA in lipid nanoparticles. This product utilizes the lipid nanoparticle (LNP) technology platform for simple and efficient delivery of the Delta variant spike protein (COVID-19) mRNA to a variety of mammalian cells, including cell cultures which may typically be prone to difficulties in expressing desired proteins.